Navigation Links
Boston Scientific Named Healthcare Supplier of the Year by Global Healthcare Exchange (GHX)
Date:4/23/2008

NATICK, Mass., April 23 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced that it has been named U.S. Healthcare Supplier of the Year in the GHXcellence Awards for achievements in improving supply chain performance. The award recognizes Boston Scientific's successful use of electronic transactions to improve supply chain efficiency for customers and suppliers.

The annual awards were granted by GHX based on application of the following criteria to an organization's performance during the 2007 calendar year:
-- Increased use of e-commerce solutions throughout the healthcare supply

chain

-- Number of trading partners with whom they conduct e-commerce

-- Percentage of orders transacted electronically

-- Percentage of invoices transacted electronically

-- Reduction in order and invoice discrepancies and errors

Boston Scientific has implemented numerous e-commerce transaction options, including electronic order placement, electronic invoicing, advance shipping notices and electronic catalogs. Currently, more than 80 percent of the Company's domestic customers employ Electronic Data Interchange (EDI) to facilitate business transactions. EDI is the electronic transfer of structured data in a standard format between businesses, organizations or other groups.

"This award acknowledges our commitment to the use of e-commerce to improve efficiency and reduce costs throughout the supply chain," said Paul LaViolette, Boston Scientific Chief Operating Officer. "Through process and software system improvements, we have been able to expand our electronic offerings and increase transaction efficiency and customer satisfaction."

"This year's GHXcell
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Philips Supports the Boston Marathon as the Sole Provider of Life-Saving Medical Devices
2. DARA Announces Surgi-Vision Agreement with Boston Scientific Corporation
3. Boston Trial to Test New HIV/AIDS Vaccine
4. Boston College biologists build a better mouse model for cancer research
5. Every Boston Red Sox Home Run Televised on NESN in 2008 to Help Children With Medical Needs
6. Boston Scientific Announces Appointment of Timothy Pratt as General Counsel
7. Boston Kids Enjoy Free Davis Vision Screenings
8. Boston Medical Center Meets Prescription Challenges With Kryptiq ePrescribing Solution
9. Transcept Pharmaceuticals to Present at Cowen and Companys 27th Annual Health Care Conference in Boston
10. Media Invited to Attend International Society for Heart & Lung Transplantation Meeting in Boston, April 9-12
11. Boston Scientific Announces First European Implants of New Devices to Treat Heart Failure and Sudden Cardiac Death
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:American Diversified Holdings Corporation Announces Stem Cell Patent Acquisition Program 2Health News:LodgeNet Interactive to Participate in UBS' 37th Annual Global Media and Communications Conference 2Health News:LodgeNet Interactive to Participate in UBS' 37th Annual Global Media and Communications Conference 3Health News:LodgeNet Interactive to Participate in UBS' 37th Annual Global Media and Communications Conference 4Health News:LodgeNet Interactive to Participate in UBS' 37th Annual Global Media and Communications Conference 5Health News:BHR Pharma Files Investigational New Drug Application, Receives Orphan Drug Designation, for Traumatic Brain Injury Treatment 2Health News:The Breema Center Presents a Yearlong Campaign to Transform Stress into Harmony in 2010 and Beyond 2Health News:LCA-Vision Joins Forces With the Wounded Warrior Project to Give the Gift of Enhanced Vision to Wounded American Heroes 2
Breaking Medicine Technology:Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 2Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 3Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 4Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 5Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 2Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 3Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 4Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 5Q-Med AB and Oceana Therapeutics, Inc. Take Major Step Towards SOLESTA(TM) US Regulatory Filing 2Q-Med AB and Oceana Therapeutics, Inc. Take Major Step Towards SOLESTA(TM) US Regulatory Filing 3Dendreon Announces Webcast Presentations at Upcoming Investor Conferences 13867 1Women Urged Not to Drink While Pregnant 56308 1Women Urged Not to Drink While Pregnant 56308 2Women Urged Not to Drink While Pregnant 56308 3Amgen to Present at the Baird Healthcare Conference 56306 1Amgen to Present at the Baird Healthcare Conference 56306 2